Trial intelligence / Profile preview

Regional vs General Anesthesia for Hip Fracture in Clopidogrel Patients

NCT03596060Unknown

Sponsor
University Hospital of Larissa
Start
Oct 2017
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of propofol injection (veterinary) and levobupivacaine in hip fracture, sponsored by University Hospital of Larissa. Primary endpoint: All-cause mortality at 30 days. Status: unknown.

02

Drugs

propofol injection (veterinary)levobupivacaine
03

Conditions

hip fracture

Beyond the preview

Go deeper on NCT03596060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03596060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call